Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) Short Interest


HKSE:02566 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd HKSE:02566
20 GF Score
Price HK$5.79
! 1 Warning Sign
View Full Analysis

What is Hangzhou Jiuyuan Genetic Biopharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:02566 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Short Interest falls into.


HKSE:02566
20GF Score
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd HKSE:02566
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Business Description

Address No. 23, Eighth Street, Baiyang Street, Qiantang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd is a biopharmaceutical company in China. It is engaged in the research & development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on four large and fast-growing therapeutic areas: orthopedics, metabolic diseases, oncology, and hematology. Centered around these therapeutic areas, it has built a diversified product portfolio comprising several marketed products, such as Jilifen, Jijufen, Jiouting, Yinuojia, Guyoudao, etc., and has several product candidates under development, such as JY54, JY23, JY47, JY56, JY29-2, etc., targeting various indications. Geographically, the company generates maximum revenue from the Chinese Mainland, and the rest from other countries.
20GF Score

Get the complete analysis for HKSE:02566

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.79
Price